HIV Care
consider in enhancing care in their services. Making HIV care available to PLHIV makes clinical sense and has the potential to save healthcare systems money they would have otherwise spent on hospitalisa- tion, defaulter tracing and second- and third-line ART.
References 1. World Health Organization (WHO). Global HIV/AIDS response: epidemic update and health sector progress towards universal access: progress report 2011. WHO: Geneva, Switzerland, 2011.
2. Chu C, Selwyn PA. An epidemic in evolution: The need for new models of HIV care in the chronic disease era. J Urban Health: Bulletin of the New York Academy of Medicine 2011; 88 :556–66.
3. Guaraldi G, Orlando G, Zona S, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 2011; 53: 1120–6.
4.
Coleman CL. Spirituality and sexual orientation: relationship to mental well- being and functional health status. J Adv Nurs 2003; 43: 457–64.
5. Holmes WC, Bilker WB, Wang H, Chapman J, Gross R. HIV/AIDS-specific quality of life and adherence to antiretroviral therapy over time. J Acquir Immune Defic Syndr 2007; 46: 323–7.
6. Lima et al, 2007 7. Bader A, Kremer H, Erlich-Trungenberger I, et al. An adherence typology: cop- ing, quality of life, and physical symptoms of people living with HIV/AIDS and their adherence to antiretroviral treatment. Med Sci Monitor 2006; 12:CR493- 500. Epub 2006 Nov 23.
8. Nakimuli-Mpungu E, Bass JK, Alexandre P, et al. Depression, alcohol use and adherence to antiretroviral therapy in sub-Saharan Africa: A systematic review. AIDS Behaviour 2011.
9.
Joint United National Programme on HIV/AIDS (UNAIDS). A new investment framework for the global HIV response: UNAIDS Issues Brief, 2011. Geneva, Switzerland: UNAIDS, 2011.
10. World Health Organization (WHO). Definition of Palliative Care. http://www.
who.int/cancer/palliative/definition/en. Accessed on January 30, 2012.
11. ART-LINC Collaboration of the International Databases to Evaluate AIDS (Ie- DEA). Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. Trop Med Int Health 2008; 13: 870–9.
12. Lawn SD, Harries AD, Wood R. Strategies to reduce early morbidity and mortal- ity in adults receiving antiretroviral therapy in resource-limited settings. Current Opinions in HIV/AIDS 2010; 1: 8–16.
13. Cornell M, Grimsrud A, Fairall L, et al. International Epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) Collaboration. Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002–2007. AIDS 2010; 10: 2263–70.
14. Etienne M, Burrows L, Ostimekem B, Macharia T, Amorosso A. Effect of varying models of adherence support on lost-to-follow-up rates: Findings from 34 treatment facilities in eight resource-limited countries. Paper presented at the 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, Abstract WEPEB101. Sydney, Australia, 2007.
15. Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub- Saharan Africa: a systematic review. PLoS Med 2011; 8: e1001056. Epub 2011 Jul 19.
16. Collins K, Harding R. Improving HIV management in sub-Saharan Africa: How much palliative care is needed? AIDS Care 2007; 19: 1304–6.
17. Green K, Tran T, Nguyen NNT, Tran VN, Nguyen THA. Improving access to pallia- tive care among people living with HIV in Vietnam: Preliminary results from an intervention study, J Pain Symptom Manage 2010: 40: 31–4.
18. Simms VM, Higginson IJ, Harding R. What Palliative Care-Related Problems Do Patients Experience at HIV Diagnosis? A Systematic Review of the Evidence. J Pain Symptom Manage 2011; 42: 734–53.
19. Farrant L, Gwyther L, Dinat N, et al. The prevalence and burden of pain and other symptoms among South Africans attending highly active antiretroviral therapy (HAART) clinics. S Afr Med J 2012; 102: 499–500.
20. Maritz J, Benatar M, Dave JA, et al. HIV neuropathy in South Africans: fre- quency, characteristics, and risk factors. Muscle Nerve 2010; 41: 599–606.
21. Pappin M, Wouters E, Booysen FL. Anxiety and depression amongst patients enrolled in a public sector antiretroviral treatment programme in South Africa: a cross-sectional study. BMC Public Health 2012; 27: 244.
22. Israelski DM, Prentiss DE, Lubega S, Psychiatric co-morbidity in vulnerable populations receiving primary care for HIV/AIDS. AIDS Care 2007; 19: 220–5.
23. Justice AC et al. Clinical importance of provider-reported HIV symptoms com- pared with patient reports. Medical Care 2001; 39: 397–408.
24. Ammassari A, Murri A, Pezzotti P, et al. Self-reported symptoms and medication side effects influence adherence to highly active retroviral therapy in persons with HIV infection. J Acq Immune Def Synd 2001; 28: 445–9.
25. Berg KM, Cooperman NA, Newville H, Arnsten JH. Self-efficacy and depression as mediators of the relationship between pain and antiretroviral therapy. AIDS Care 2009; 21: 244–8.
26. Gay C, Portillo CJ, Kelly R, et al. Self-reported medication adherence and symp- tom experience in adults with HIV. J Ass Nurses AIDS Care 2011; 22: 257–68.
27. Heath KV et al. Intentional Nonadherence due to adverse symptoms associated with antiretroviral therapy. J Acq Immune Def Synd 2002; 32: 211–17.
28. Sherr L, Lampe F, Norwood S, et al. Adherence to antiretroviral treatment in patients with HIV in the UK: a study of complexity. AIDS Care 2008; 20: 442–8.
29. Lucey BP, Clifford DB, Creighton J, et al. Relationship of depression and catastrophizing to pain, disability, and medication adherence in patients with HIV-associated sensory neuropathy. AIDS Care 2011; 23: 921–8.
30. Gordillo V, del Amo J, Soriano V, González-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS
1999; 13: 1763–9.
31. Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychometric Med 2008; 70: 539–45.
32. Gonzalez JS, Batchelder AW, Psaros C, Safren SA. Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. J Acquir Immune Defic Syndr 2011; 58: 181–7.
33. Holzemer WL. HIV and AIDS: The symptom experience. What cell counts and viral loads won’t tell you. Amer J Nursing 2002; 102: 48–52.
34. Johnson MO, Dilworth SE, Neilands TB, et al; NIMH HLP team. Predictors of attrition among high risk HIV-infected participants enrolled in a multi-site prevention trial. AIDS Behav 2008;12: 974–7. Epub 2008 Jan 18.
35. Dudgeon D, Vaitonis V, Seow H, et al. Ontario, Canada: Using networks to integrate palliative care province-wide, J Pain Sympt Manage 2007; 33: 640–4.
36. World Health Organization (WHO). Integrated health services: What and why? 2008a
http://www.who.int/healthsystems/service_delivery_techbrief1.pdf.
37. Kennedy C, Lindegren ML, Brickley DB, et al. Integration of maternal, neonatal and child health and nutrition, family planning and HIV: Current evidence and practice from a systematic Cochrane Review. Washington DC: PEPFAR, CDC and USAID, 2011.
38. Atun R, de Jongh Y, Secci F, Ohiri K, Adeyi O. Integration of targeted health interventions into health systems: a conceptual framework for analysis. Health Policy Plann 2010; 25: 104–11.
39. World Health Organization (WHO). Primary health care – now more than ever. Switzerland, Geneva: WHO, 2008b.
http://www.who.int/whr/2008/whr08_ en.pdf.
40. Achieng L, Musangi H, Ong’uti S, et al. An Observational Cohort Comparison of Facilitators of Retention in Care and Adherence to Anti-Eetroviral Therapy at an HIV Treatment Center in Kenya. Plos One 2012; 7. [Epub ahead of print]
41. Kabore I, Bloem J, Etheredge G, et al. The effect of community-based support services on clinical efficacy and health-related quality of life in HIV/AIDS patients in resource-limited settings in sub-Saharan Africa. AIDS Patient Care STDs 2010; 24: 581–94.
42. Zachariah R, Teck R, Bihendwa L, et al. Community support is associated with better antiretroviral treatment outcomes in a resource-limited rural district in Malawi. Trans Roy Soci Trop Med Hygiene 2007; 101: 79–84.
43. Green K, Tran T, Tran VN, et al. Injecting drug use, gender and home-based care: Factors associated with depression, anxiety and social support in people living with HIV in Northern Viet Nam. 140th
Annual Meeting, San Francisco, CA, October 27-31, 2012c.
44. Green K, Tran T, Tran VN, et al. Putting the quality back into HIV care: Results from an intervention study in Northern Vietnam. International AIDS Confer- ence, Washington, DC, July 22–27, 2012a.
45. Barton PL, Davidson AJ, Kobayashi JS, Maravi M, Yun LWH. Antidepressant Treatment Improves Adherence to Antiretroviral Therapy Among Depressed HIV-Infected Patients. J Acquir Immune Defic Syndr 2005; 38: 432–8.
46. Chiou PY, Kuo BIT, Lee MB, et al. A programme of symptom management for improving quality of life and drug adherence in AIDS/HIV patients. Iss Innov Nurs Pract 2006; 55: 167–79.
47. Horberg MA, Silverberg MJ, Hurley LB, et al. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acq Imm Def Synd 2008; 47: 384–90.
48. Yun LWH, Maravi M, Kobayashi LS, Barton P, Davidson AJ. Antidepressant treatment improved adherence to antiretroviral therapy among depressed HIV- infected patients. J Acq Imm Def Synd 2005; 38: 432–8.
49. Green K, Arnolda G, Nguyen CQ, Vu NP, Nguyen TTH. Integration of palliative care into routine HIV outpatient services: findings from an intervention evalua- tion in Quang Ninh, Vietnam. Hanoi, Vietnam: FHI 360, 2012b.
50. Selman L, Harding R, Agupio G, et al. What effect does palliative care have on HIV-infected patients’ quality of life? – results from an international, multi- centred longitudinal study. AIDS 2008 - XVII International AIDS Conference: Abstract no. TUPE0171.
51. Morrison RS, Penrod JD, Cassel JB, et al; for the Palliative Care Leadership Centers’ Outcomes Group. Cost savings associated with US hospital palliative care consultation programs. Arch Intern Med 2008; 168: 1783–90.
52. Lampe FC, Harding R, Smith CJ, Phillips AN, Johnson M, Sherr L. Physical and psychological symptoms and risk of virologic rebound among patients with virologic suppression on antiretroviral therapy. J Acq Imm Def Synd 2010; 54: 500–5.
American Public Health Association
July 2012
Africa Health 21
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68